Skip to main content

News

Hydroxychloroquine, antimalarial drug touted by President Trump, is linked to increased risk of death in coronavirus patients, study says

By The Washington Post  
   May 22, 2020

A study of 96,000 hospitalized coronavirus patients on six continents found that those who received an antimalarial drug promoted by President Trump as a “game changer” in the fight against the virus had a significantly higher risk of death compared with those who did not.

Full story


Get the latest on healthcare leadership in your inbox.